肩峰下减压术与诊断性关节镜治疗肩峰撞击综合征的随机安慰剂手术对照试验
该多中心、三组、随机双盲假手术对照试验纳入210例肩峰撞击综合征患者,比较肩峰下减压术(ASD)、诊断性关节镜(安慰剂)和运动疗法。24个月时,ASD与诊断性关节镜在静息和活动时疼痛VAS评分上均无临床相关差异;ASD与运动疗法比较虽有统计学差异但未超过最小临床重要差异阈值。结论:ASD较安慰剂手术无额外获益。
要点
- ASD与诊断性关节镜在24个月时疼痛改善无临床相关差异。
- ASD与运动疗法比较的差异未超过最小临床重要差异阈值。
- ASD与诊断性关节镜在次要结局和不良事件上无组间差异。
核心结论
- 在肩峰撞击综合征患者中,肩峰下减压术在24个月时较诊断性关节镜无获益。
研究设计与样本
- 多中心、三组、随机双盲假手术对照试验,在芬兰三家公立医院骨科进行。
- 共纳入210例符合肩峰撞击综合征症状的患者,2005年2月1日开始入组,2015年6月25日完成两年随访。
- 干预措施为肩峰下减压术、诊断性关节镜(安慰剂对照)和运动疗法。
主要发现
- 意向性治疗分析中,ASD组24个月静息疼痛VAS平均变化36.0,活动时55.4;诊断性关节镜组分别为31.4和47.5。
- ASD减诊断性关节镜的组间平均差异:静息VAS -4.6(95%CI -11.3至2.1,P=0.18),活动VAS -9.0(95%CI -18.1至0.2,P=0.054)。
- ASD与诊断性关节镜在次要结局和不良事件上无组间差异。
- ASD与运动疗法比较:静息VAS差异-7.5(95%CI -14.0至-1.0,P=0.023),活动VAS差异-12.0(95%CI -20.9至-3.2,P=0.008),均未超过预设最小临床重要差异15。
关键数值与推荐
- 最小临床重要差异阈值预设为15(VAS 0-100)。
- ASD与诊断性关节镜组间差异未达最小临床重要差异阈值。
- ASD与运动疗法比较的差异虽有统计学意义但未超过最小临床重要差异阈值。
临床怎么用
- 对于肩峰撞击综合征患者,肩峰下减压术不应被视为优于安慰剂手术的常规选择。
局限性
- ASD与运动疗法比较缺乏盲法,且因ASD组选择性移除可能预后不良的患者而可能偏向ASD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy of arthroscopic subacromial decompression (ASD) by comparing it with diagnostic arthroscopy, a placebo surgical intervention, and with a non-operative alternative, exercise therapy, in a more pragmatic setting. DESIGN: Multicentre, three group, randomised, double blind, sham controlled trial. SETTING: Orthopaedic departments at three public hospitals in Finland. PARTICIPANTS: 210 patients with symptoms consistent with shoulder impingement syndrome, enrolled from 1 February 2005 with two year follow-up completed by 25 June 2015. INTERVENTIONS: ASD, diagnostic arthroscopy (placebo control), and exercise therapy. MAIN OUTCOME MEASURES: Shoulder pain at rest and on arm activity (visual analogue scale (VAS) from 0 to 100, with 0 denoting no pain), at 24 months. The threshold for minimal clinically important difference was set at 15. RESULTS: In the primary intention to treat analysis (ASD versus diagnostic arthroscopy), no clinically relevant between group differences were seen in the two primary outcomes at 24 months (mean change for ASD 36.0 at rest and 55.4 on activity; for diagnostic arthroscopy 31.4 at rest and 47.5 on activity). The observed mean difference between groups (ASD minus diagnostic arthroscopy) in pain VAS were -4.6 (95% confidence interval -11.3 to 2.1) points (P=0.18) at rest and -9.0 (-18.1 to 0.2) points (P=0.054) on arm activity. No between group differences were seen between the ASD and diagnostic arthroscopy groups in the secondary outcomes or adverse events. In the secondary comparison (ASD versus exercise therapy), statistically significant differences were found in favour of ASD in the two primary outcomes at 24 months in both VAS at rest (-7.5, -14.0 to -1.0, points; P=0.023) and VAS on arm activity (-12.0, -20.9 to -3.2, points; P=0.008), but the mean differences between groups did not exceed the pre-specified minimal clinically important difference. Of note, this ASD versus exercise therapy comparison is not only confounded by lack of blinding but also likely to be biased in favour of ASD owing to the selective removal of patients with likely poor outcome from the ASD group, without comparable exclusions from the exercise therapy group. CONCLUSIONS: In this controlled trial involving patients with a shoulder impingement syndrome, arthroscopic subacromial decompression provided no benefit over diagnostic arthroscopy at 24 months. TRIAL REGISTRATION: Clinicaltrials.gov NCT00428870.
引用
- Paavola M, Malmivaara A, Taimela S, et al. Subacromial decompression versus diagnostic arthroscopy for shoulder impingement: randomised, placebo surgery controlled clinical trial. BMJ. 2018. PMID: 30026230. doi:10.1136/bmj.k2860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。